Venture capital investor The Capital Fund has directed £250,000 towards the development of a revolutionary low-cost medical pump, developed by PDD Innovations.
Venture capital investor The Capital Fund has directed £250,000 towards the development of a revolutionary low-cost medical pump, developed by PDD Innovations.
The SECTA infusion pump is currently in development for use in intravenous drips, with a trial being conducted at St Bartholomew’s Hospital in London, after attracting strong interest at the recent Medical Device Technology Exhibition.
Ian Cameron, London-focused Capital’s investment director believes ‘PDD Innovations has created a truly innovative, disruptive pump technology that has huge potential for applications across a range of sectors, where it could generate considerable cost-savings. We are pleased to provide the funding PDD Innovations needs to take the SECTA product to the next stage.
